Red Light Holland Reports 20.3% Revenue Growth YoY, Remains 'Strategically Focused On The Long Game'
Red Light Holland Reports 20.3% Revenue Growth YoY, Remains 'Strategically Focused On The Long Game'
Red Light Holland Corp. (CSE:TRIP) (OTCQB:TRUFF) reported its financial results Monday for the year ended March 31, 2024, revealing annual revenue of CA$4.7 million ($3.4 million), up by 20.3% from CA$3.9 million in the prior year.
Red Light Holland Corp. (CSE:TRIP) (OTCQB:TRUFF) 報告了截至2024年3月31日的財年財務業績，年收入爲CA$470萬($340萬)，比去年的CA$390萬增長了20.3%。
The Ontario-based producer of psilocybin truffles, functional mushrooms and mushroom home-grow kits went public with zero sales in May 2020. Since then until March 31, 2024, Red Light achieved CA$11.0 million in sales.
這家總部位於安大略省的生產者，在2020年5月零銷售的情況下上市。自那時起直到2024年3月31日，Red Light實現了總銷售額爲CA$1100萬。
"The entire team at Red Light Holland is proud of our 2024 audited year-end results, as we continue to grow our revenues," Todd Shapiro, Red Light Holland CEO and director, said in a statement. "We remain strategically focused on the long game, while other companies in our space continue to burn cash at a frightening rate, have small runways, or march towards the eve of insolvency as the overall sector, to be frank, has been unimpressive. In our opinion, the harsh reality is that governments are uncertain, even despite recent groundbreaking emerging psilocybin developments, on their direct path forward – hence they are slower to introduce this much needed therapeutic approach to patients in need."
Red Light Holland CEO兼董事Todd Shapiro在一份聲明中表示：“Red Light Holland整個團隊爲我們的2024財年末審計業績感到自豪，我們繼續增長營收。在其他公司在我們的行業板塊繼續以驚人的速度燒錢、擁有較短的路程或逼近破產的前夕的同時，我們保持着戰略性的集中，而整個行業板塊，坦率地說，令人印象深刻。我們認爲，殘酷的現實是，即使是在最近取得突破性進展的幻蘑菇領域，政府對於其直接未來路徑也存在不確定性，因此他們在向病人推廣這種急需的治療方法上會較爲緩慢。”
Read Also: Canadian Biotech Duo Hits Psilocybin Extraction Milestone For API Development At Scale
也可以閱讀：加拿大生物技術公司雙擊幻蘑菇提取里程碑 再獲得大規模 API 開發許可
FY 2024 Financial Highlights
2024財年財務亮點
- Net loss amounted to CA$7.71 million, compared to CA$5.8 million in the previous year.
- Gross profit was CA$2.02 million, compared to CA$1.71 million in 2023.
- Gross profit margin was 42.5%, versus 43.3% in the prior year.
- Cash burn was CA$3.3 million, compared to CA$3.8 million in 2023.
- At the end of the reporting period, the company had a cash balance of CA$14.1 million, compared to CA$18.29 million on March 31, 2023.
- Total assets amounted to CA$24.08 million, compared to CA$30.14 million on March 31, 2023.
- 淨虧損爲CA$771萬，而上一年爲CA$580萬。
- 毛利潤爲CA$202萬，而2023年爲CA$171萬。
- 毛利率爲42.5%，而去年爲43.3%。
- 現金流出爲CA$330萬，而2023年爲CA$380萬。
- 報告期末，公司現金餘額爲CA$1410萬，而2023年3月31日爲CA$1829萬。
- 總資產爲CA$2408萬，而2023年3月31日爲CA$3014萬。
"Red Light Holland had anticipated this slower path, which is why we are pleased with our pivot a few years ago creating our 'everything mushroom' vision," Shapiro continued, "Our core focus remains on profitability while we continue to advocate for the 'right to try' and push for adult access to psilocybin for those in need – and our hard work, goals, and strategy continue to show positive momentum."
Shapiro繼續說：“Red Light Holland原本就預料到了這種緩慢的發展路徑，這就是爲什麼幾年前我們轉向創建我們的“everything mushroom”願景，我們的核心重心仍然在盈利，同時我們繼續倡導‘有權嘗試’並推動成年人獲得他們需要的幻蘑菇 – 我們的辛勤工作、目標和策略繼續顯示出積極的勢頭。”
Price Action
股價變動
Red Light Holland shares closed Monday market session 2.78% lower at $0.035 per share.
Red Light Holland股票週一收盤下跌了2.78%，每股價格爲$0.035。
- Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
- Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
- 迷幻藥頭條新聞：預防癡呆，心理彈性，古羅馬之旅等。
- 致幻藥：新證據顯示幻蘑菇可作爲焦慮療法，易用的開放式學習對治療師的幫助，Enveric的許可協議與更多細節
More about investments and financial data from the industry you can hear at the 19th Benzinga Cannabis Capital Conference in Chicago this October 8-9. Engage with top executives, investors, policymakers, and advocates to explore the industry's future. Secure your tickets now before prices increase by following this link.
有關行業中的投資和財務數據的更多信息，請參加今年10月8-9日在芝加哥舉行的 第19屆Benzinga大麻資本會議將於10月8日至9日在芝加哥舉行，屆時將有頂級CEO、投資者和大麻產業領袖齊聚一堂。請通過以下鏈接獲取門票，在價格上漲之前儘快購買。 ，與高管、投資者、決策者和倡導者互動，探討行業的未來。立即購票，在價格上漲之前獲得會議門票。 此鏈接.
Photo created with AI
使用人工智能創建的圖片
譯文內容由第三人軟體翻譯。
